Research map: Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real‐World Study

Back to the article

Papers in this map

  1. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis · Steven R. Ytterberg · 2022 · 1819 citations · Cited by this paper
  2. Paracetamol‐Induced Generalized Bullous Fixed Drug Eruption With Positive Anti‐ BP230 Antibody and Confirmed With Oral Provocation Test in a Child: A Case Report From the Philippines · 2026 · Related
  3. Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study · Ida Vittrup · 2024 · 13 citations · Cited by this paper
  4. Long Distance Non‐Contact Dermoscopy: Technological Foundations, Clinical Applications, and Future Directions · 2026 · Related
  5. Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis · 2026 · Related
  6. The Emerging Therapeutic Landscape of Bullous Pemphigoid: A Systematic Registry‐Based Analysis of Clinical Trials (2015–2025) · 2026 · Related
  7. Retronychia Inversa: Insights Into a Newly Defined Nail Condition · 2026 · Related
  8. The “Stamp‐n‐Tack” Technique: An Ink‐Guided Precision Method for Anchoring Tissue After Releasing Facial Retaining Ligaments in Large Facial Flap Reconstruction · 2026 · Related
  9. Sustained Minimal Disease Activity With Upadacitinib and Abrocitinib in Moderate‐to‐Severe Atopic Dermatitis: A 104‐Week, Real‐World, Retrospective Study · 2026 · Related
  10. Lichen Sclerosus Is Associated With an Increased Risk of Anal Cancer: A TriNetX Retrospective Cohort Study · 2026 · Related
  11. The Association Between Vitiligo and Uveitis: A Large Population‐Based Study · 2026 · Related
  12. Severity‐Associated Multidimensional Burden in Hidradenitis Suppurativa: A Cross‐Sectional Registry Study · 2026 · Related

Source: OpenAlex (CC0)